United Orthopedic Corporation (TPEX:4129)
112.00
+0.50 (0.45%)
Dec 31, 2025, 1:30 PM CST
United Orthopedic Market Cap
United Orthopedic has a market cap or net worth of 10.8 billion as of December 31, 2025. Its market cap has increased by 15.76% in one year.
Market Cap
10.80B
Enterprise Value
12.28B
Revenue
5.46B
Ranking
n/a
PE Ratio
19.79
Stock Price
112.00
Market Cap Chart
Since September 2, 2004, United Orthopedic's market cap has increased from 318.84M to 10.80B, an increase of 3,287.60%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 10.80B | 21.39% |
| Dec 31, 2024 | 8.90B | 19.51% |
| Dec 29, 2023 | 7.44B | 99.39% |
| Dec 30, 2022 | 3.73B | 51.75% |
| Dec 30, 2021 | 2.46B | -24.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 31.06B |